Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Dec;62(12):1128–1132. doi: 10.1136/ard.2003.011023

Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review

C Keller 1, A Webb 1, J Davis 1
PMCID: PMC1754419  PMID: 14644847

Full Text

The Full Text of this article is available as a PDF (185.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baeten D., Van Damme N., Van den Bosch F., Kruithof E., De Vos M., Mielants H., Veys E. M., De Keyser F. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha. Ann Rheum Dis. 2001 Aug;60(8):750–755. doi: 10.1136/ard.60.8.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brandt J., Haibel H., Cornely D., Golder W., Gonzalez J., Reddig J., Thriene W., Sieper J., Braun J. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum. 2000 Jun;43(6):1346–1352. doi: 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  3. Braun J., Bollow M., Neure L., Seipelt E., Seyrekbasan F., Herbst H., Eggens U., Distler A., Sieper J. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995 Apr;38(4):499–505. doi: 10.1002/art.1780380407. [DOI] [PubMed] [Google Scholar]
  4. Braun J., Sieper J., Breban M., Collantes-Estevez E., Davis J., Inman R., Marzo-Ortega H., Mielants H. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Ann Rheum Dis. 2002 Dec;61 (Suppl 3):iii51–iii60. doi: 10.1136/ard.61.suppl_3.iii51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braun J., Xiang J., Brandt J., Maetzel H., Haibel H., Wu P., Kohler S., Rudwaleit M., Siegert S., Radbruch A. Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences. Ann Rheum Dis. 2000 Nov;59 (Suppl 1):i85–i89. doi: 10.1136/ard.59.suppl_1.i85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Braun J., de Keyser F., Brandt J., Mielants H., Sieper J., Veys E. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol. 2001 Jul;13(4):245–249. doi: 10.1097/00002281-200107000-00001. [DOI] [PubMed] [Google Scholar]
  7. Calin A., Garrett S., Whitelock H., Kennedy L. G., O'Hea J., Mallorie P., Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994 Dec;21(12):2281–2285. [PubMed] [Google Scholar]
  8. Cañete J. D., Llena J., Collado A., Sanmartí R., Gayá A., Gratacós J., Blay M., Muñoz-Gómez J. Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies. Br J Rheumatol. 1997 Jan;36(1):38–42. doi: 10.1093/rheumatology/36.1.38. [DOI] [PubMed] [Google Scholar]
  9. Cañete J. D., Martínez S. E., Farrés J., Sanmartí R., Blay M., Gómez A., Salvador G., Muñoz-Gómez J. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis. 2000 Apr;59(4):263–268. doi: 10.1136/ard.59.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chu C. Q., Field M., Feldmann M., Maini R. N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Sep;34(9):1125–1132. doi: 10.1002/art.1780340908. [DOI] [PubMed] [Google Scholar]
  11. Claudepierre P., Rymer J. C., Authier F. J., Allanore Y., Larget-Piet B., Gherardi R., Chevalier X. A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies. Br J Rheumatol. 1997 Mar;36(3):400–401. doi: 10.1093/rheumatology/36.3.400. [DOI] [PubMed] [Google Scholar]
  12. Claudepierre P., Rymer J. C., Chevalier X. IL-10 plasma levels correlate with disease activity in spondyloarthropathy. J Rheumatol. 1997 Aug;24(8):1659–1661. [PubMed] [Google Scholar]
  13. Gorman Jennifer D., Sack Kenneth E., Davis John C., Jr Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002 May 2;346(18):1349–1356. doi: 10.1056/NEJMoa012664. [DOI] [PubMed] [Google Scholar]
  14. Gratacós J., Collado A., Filella X., Sanmartí R., Cañete J., Llena J., Molina R., Ballesta A., Muñoz-Gómez J. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol. 1994 Oct;33(10):927–931. doi: 10.1093/rheumatology/33.10.927. [DOI] [PubMed] [Google Scholar]
  15. Gu J., Märker-Hermann E., Baeten D., Tsai W. C., Gladman D., Xiong M., Deister H., Kuipers J. G., Huang F., Song Y. W. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002 Jul;41(7):759–766. doi: 10.1093/rheumatology/41.7.759. [DOI] [PubMed] [Google Scholar]
  16. Gu Jieruo, Rihl Markus, Märker-Hermann Elisabeth, Baeten Dominique, Kuipers Jens G., Song Yeong Wook, Maksymowych Walter P., Burgos-Vargas Ruben, Veys Eric M., De Keyser Filip. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol. 2002 Oct;29(10):2159–2164. [PubMed] [Google Scholar]
  17. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  18. Mander M., Simpson J. M., McLellan A., Walker D., Goodacre J. A., Dick W. C. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis. 1987 Mar;46(3):197–202. doi: 10.1136/ard.46.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miossec P., van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997 Dec;40(12):2105–2115. doi: 10.1002/art.1780401203. [DOI] [PubMed] [Google Scholar]
  20. Moreland L. W., Schiff M. H., Baumgartner S. W., Tindall E. A., Fleischmann R. M., Bulpitt K. J., Weaver A. L., Keystone E. C., Furst D. E., Mease P. J. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med. 1999 Mar 16;130(6):478–486. doi: 10.7326/0003-4819-130-6-199903160-00004. [DOI] [PubMed] [Google Scholar]
  21. Ritchlin C., Haas-Smith S. A., Hicks D., Cappuccio J., Osterland C. K., Looney R. J. Patterns of cytokine production in psoriatic synovium. J Rheumatol. 1998 Aug;25(8):1544–1552. [PubMed] [Google Scholar]
  22. Rudwaleit M., Siegert S., Yin Z., Eick J., Thiel A., Radbruch A., Sieper J., Braun J. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis. 2001 Jan;60(1):36–42. doi: 10.1136/ard.60.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sonel Birkan, Tutkak Hüseyin, Düzgün Nursen. Serum levels of IL-1 beta, TNF-alpha, IL-8, and acute phase proteins in seronegative spondyloarthropathies. Joint Bone Spine. 2002 Oct;69(5):463–467. doi: 10.1016/s1297-319x(02)00431-1. [DOI] [PubMed] [Google Scholar]
  24. Toussirot E., Lafforgue P., Boucraut J., Despieds P., Schiano A., Bernard D., Acquaviva P. C. Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies. Rheumatol Int. 1994;13(5):175–180. doi: 10.1007/BF00390264. [DOI] [PubMed] [Google Scholar]
  25. Van Damme N., De Vos M., Baeten D., Demetter P., Mielants H., Verbruggen G., Cuvelier C., Veys E. M., De Keyser F. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis. 2001 May;60(5):495–499. doi: 10.1136/ard.60.5.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zou Jianxiang, Rudwaleit Martin, Brandt Jan, Thiel Andreas, Braun Jürgen, Sieper Joachim. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Arthritis Rheum. 2003 Mar;48(3):780–790. doi: 10.1002/art.10847. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES